330 related articles for article (PubMed ID: 32689862)
1. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Di Minno A; Lupoli R; Calcaterra I; Poggio P; Forte F; Spadarella G; Ambrosino P; Iannuzzo G; Di Minno MND
J Am Heart Assoc; 2020 Aug; 9(15):e016262. PubMed ID: 32689862
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis.
Cicero AFG; Fogacci F; Hernandez AV; Banach M;
PLoS Med; 2020 Jul; 17(7):e1003121. PubMed ID: 32673317
[TBL] [Abstract][Full Text] [Related]
3. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials.
Zhao X; Ma X; Luo X; Shi Z; Deng Z; Jin Y; Xiao Z; Tan L; Liu P; Jiang S; Shu Y; Tang B; Qiu C
BMC Pharmacol Toxicol; 2020 Dec; 21(1):86. PubMed ID: 33276805
[TBL] [Abstract][Full Text] [Related]
5. Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials.
Bhagavathula AS; Al Matrooshi NO; Clark CCT; Rahmani J
Clin Drug Investig; 2021 Jan; 41(1):19-28. PubMed ID: 33368025
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA
Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030
[TBL] [Abstract][Full Text] [Related]
7. Effect of Bempedoic Acid on atherogenic lipids and inflammation: A meta-analysis.
Masson W; Lobo M; Lavalle-Cobo A; Molinero G
Clin Investig Arterioscler; 2021; 33(3):117-126. PubMed ID: 33328138
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of ETC-1002 in hypercholesterolaemic patients: a meta-analysis of randomised controlled trials.
Wang X; Luo S; Gan X; He C; Huang R
Kardiol Pol; 2019; 77(2):207-216. PubMed ID: 30740643
[TBL] [Abstract][Full Text] [Related]
9. Bempedoic acid for the treatment of hypercholesterolemia.
Yang J
Expert Rev Cardiovasc Ther; 2020 Jul; 18(7):373-380. PubMed ID: 32532162
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis.
Wang X; Zhang Y; Tan H; Wang P; Zha X; Chong W; Zhou L; Fang F
Cardiovasc Diabetol; 2020 Aug; 19(1):128. PubMed ID: 32787939
[TBL] [Abstract][Full Text] [Related]
11. Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
Bays HE; Banach M; Catapano AL; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Bloedon LT; Sasiela WJ; Ye Z; Ballantyne CM
J Clin Lipidol; 2020; 14(5):649-659.e6. PubMed ID: 32980290
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM;
N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: A systematic review and meta-analysis of randomized controlled trials.
Dai L; Zuo Y; You Q; Zeng H; Cao S
Eur J Prev Cardiol; 2021 Jul; 28(8):825-833. PubMed ID: 34298558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
Laufs U; Banach M; Mancini GBJ; Gaudet D; Bloedon LT; Sterling LR; Kelly S; Stroes ESG
J Am Heart Assoc; 2019 Apr; 8(7):e011662. PubMed ID: 30922146
[TBL] [Abstract][Full Text] [Related]
15. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB
JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986
[TBL] [Abstract][Full Text] [Related]
16. Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial.
Lalwani ND; Hanselman JC; MacDougall DE; Sterling LR; Cramer CT
J Clin Lipidol; 2019; 13(4):568-579. PubMed ID: 31202641
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.
De Filippo O; D'Ascenzo F; Iannaccone M; Bertaina M; Leone A; Borzillo I; Ravetti E; Solano A; Pagliassotto I; Nebiolo M; Bruno F; Giacobbe F; Muscoli S; Monticone S; Brizzi MF; Biondi Zoccai G; De Ferrari GM
Cardiovasc Diabetol; 2023 Nov; 22(1):324. PubMed ID: 38017541
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
19. Bempedoic Acid (ETC-1002): ATP Citrate Lyase Inhibitor: Review of a First-in-Class Medication with Potential Benefit in Statin-Refractory Cases.
Zagelbaum NK; Yandrapalli S; Nabors C; Frishman WH
Cardiol Rev; 2019; 27(1):49-56. PubMed ID: 29939848
[TBL] [Abstract][Full Text] [Related]
20. Bempedoic Acid: A New Drug for an Old Problem.
Nguyen D; Du N; Sulaica EM; Wanat MA
Ann Pharmacother; 2021 Feb; 55(2):246-251. PubMed ID: 32674598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]